Today: 30 April 2026
GE Aerospace stock price slips after hours as 2026 guidance keeps investors on edge

GE Aerospace stock price slips after hours as 2026 guidance keeps investors on edge

New York, January 23, 2026, 18:52 (EST) — Trading after hours

GE Aerospace shares slipped 0.4% to $293.87 in after-hours trading Friday, bouncing between $290.10 and $299.31 earlier in the session.

The shift follows traders digging into GE’s first full-year outlook, released alongside its results and 2026 targets just a day ago. The focus has moved beyond the quarter, centering instead on what needs to fall into place going forward.

The stock now hinges entirely on jet-engine maintenance demand. This “aftermarket” segment — covering parts and repairs after an engine is in service — can generate consistent cash flow, but it drags GE into ongoing price battles with airlines.

On Thursday, GE reported adjusted fourth-quarter earnings of $1.57 per share, with adjusted revenue up 20%. The company projected adjusted EPS for 2026 between $7.10 and $7.40. It also forecast free cash flow in the range of $8.0 billion to $8.4 billion and noted a backlog near $190 billion. CEO Larry Culp described the past year as “outstanding” and said GE is entering 2026 with “solid momentum.” GE Aerospace

Reuters reported that the 2026 outlook hinges on strong aftermarket parts and maintenance demand, as aircraft deliveries remain limited. GE noted that over 70% of its commercial engine revenue comes from parts and services. The company expects adjusted revenue to climb by a low double-digit percentage in 2026, with mid-teens growth forecasted for its commercial engines and services segment, Reuters said.

Culp has publicly rejected airline claims that engine manufacturers are exploiting shortages and extended repair times to hike prices, Reuters reports. He argued that pricing factors in roughly $3 billion annually for R&D and highlighted durability improvements on the LEAP engine, developed jointly with Safran under the CFM International partnership.

On Friday, UBS lifted its price target to $374 from $368 and reaffirmed a Buy rating, describing the quarter as “solid overall with strong underlying fundamentals.” The firm also called the guidance conservative. UBS attributed the post-results dip to “the high bar and demanding valuation.” Investing.com

RBC Capital kept its Outperform rating and $355 price target, calling the recent drop “an attractive buying opportunity.” The firm did note worries over first-quarter 2026 profit growth and the absence of a refreshed 2028 outlook. Investing.com

Goldman Sachs raised its price target to $350 from $338 and stuck with a buy rating, MarketBeat reported. This move adds to a series of upbeat calls, aiming to cast the recent selloff as a reset following a strong rally.

The stock already reflects smooth execution. Should supply-chain disruptions occur, shop-visit capacity tighten, or airlines push for tougher contract terms, the downside is straightforward: margins stall and the multiple contracts.

GE will release its first-quarter 2026 report on April 21. Investors will be watching closely for signs that the services ramp and delivery cadence are on target, and that cash conversion remains above 100%.

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Coinbase stock slides after-hours as Onramp hits latency — what traders watch next week
Previous Story

Coinbase stock slides after-hours as Onramp hits latency — what traders watch next week

CoreWeave (CRWV) stock price swings late as insider sale filing and lawsuit keep shares in focus
Next Story

CoreWeave (CRWV) stock price swings late as insider sale filing and lawsuit keep shares in focus

Go toTop